The management of Richter's transformation: current approaches and future outlooks

The management of Richter's transformation: current approaches and future outlooksПодробнее

The current SoC in Richter’s transformation and the potential role of CAR T-cell therapyПодробнее

Richter’s Syndrome: Risk, predictors, and treatmentПодробнее

Promising agents emerging for Richter’s transformationПодробнее

Novel treatment strategies for Richter’s transformationПодробнее

Designing Research Trials for Richter’s Transformation - Dr. Adam KittaiПодробнее

Novel treatment regimens under investigation for Richter's transformationПодробнее

Novel approaches in Richter's transformation: CAR-T and bispecificsПодробнее

Treatment strategies under investigation for Richter's transformationПодробнее

The use of NGS in the diagnosis and treatment of Richter’s transformationПодробнее

Pirtobrutinib for Richter's Transformation - Dr. William Wierda ASH 2023Подробнее

The genomics of Richter's transformation and evolutionary history of RT from CLLПодробнее

Advances in mouse models for studying CLL and Richter's transformationПодробнее

Risk-factors for Richter’s transformationПодробнее

Case 3: Therapeutic Approaches for Richter TransformationПодробнее

In-vivo modeling of CLL and Richter's transformationПодробнее

Promising therapies for Richter's transformation: ven-R-CHOP, epcoritamab, pirtobrutinib & CAR-TПодробнее

The combination of copanlisib and nivolumab in patient's with Richter's transformationПодробнее

A research update in Richter's transformation from ASH 2023Подробнее

Var-cel shows promise for the treatment of CLL and Richter's transformationПодробнее